podcast
details
.com
Print
Share
Look for any podcast host, guest or anyone
Search
Showing episodes and shows of
Nancy Volkers
Shows
Innovating Leadership: Co-Creating Our Future
S3-Ep4: Deloitte’s Dean Explains Why Your Old Leadership Style Doesn’t Work Anymore
Guests: Gill Hickman, Jepson School of Leadership Studies Professor Emerita; Jorrit Volkers, dean of Deloitte University EMEA; and Cynthia Cherrey, CEO of the International Leadership Association “CEO clashes with their own corporate culture.” That’s the subtext of business headlines at least once a week. What’s going on? Simply put: they’re sticking with their old leadership styles, even though the world – and their own organization – has changed around them. The solution is simple: change…and change quicky. That’s the underlying message for our guests, as Gill, Jorrit, and Cynthia talk with host Maureen...
2024-10-22
36 min
Sharp Waves: ILAE's epilepsy podcast
Artificial intelligence and epilepsy: Dr. Christian Bosselmann
Send comments and feedbackDiscussions of artificial intelligence and ChatGPT are everywhere. How will this technology affect epilepsy research and care? What are the dangers and pitfalls, and what do we need to know when designing research studies that use AI technology?Dr. Alina Ivaniuk interviewed Dr. Christian Bosselmann, an epilepsy precision medicine research fellow at the Cleveland Clinic, about the history of chatbots, the promise and pitfalls of artificial intelligence, and tips for critically evaluating studies that utilize AI.Mentioned in the discussion: Are AI language models such as ChatGPT ready...
2023-06-05
36 min
Sharp Waves: ILAE's epilepsy podcast
NORSE/FIRES: International recommendations for diagnosis and treatment
Send comments and feedbackFirst-line immunotherapy and the ketogenic diet are two main recommendations for treatment of NORSE/FIRES of unknown cause, according to results from an international consensus group published in Epilepsia.Dr. Maryam Nabavi Nouri interviews first author Dr. Ronny Wickstrom.For cases with unknown etiology, first-line immunotherapy should be considered within 72 hours of seizure onset, and second-line immunotherapy and the ketogenic diet should be considered within 7 days of seizure onset.The recommendations and clinical tools are available now:International consensus recommendations for management of new-onset refractory s...
2022-11-14
22 min